Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP490846.RAKW0fnF--VY9rWH-674mYCL8A7CsL7AVBJ3eAypkVytw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP490846.RAKW0fnF--VY9rWH-674mYCL8A7CsL7AVBJ3eAypkVytw130_assertion type Assertion NP490846.RAKW0fnF--VY9rWH-674mYCL8A7CsL7AVBJ3eAypkVytw130_head.
- NP490846.RAKW0fnF--VY9rWH-674mYCL8A7CsL7AVBJ3eAypkVytw130_assertion description "[We enrolled 3819 Japanese type 2 diabetic subjects (males 60.8%, 60.6�10.0 years old) and determined their genotypes regarding glutamate-cysteine ligase modifier subunit (GCLM) C-588T, manganese superoxide dismutase (SOD2) Val16Ala, endothelial nitric oxide synthase (NOS3) G894T, NAD(P)H oxidase p22phox (CYBA) C242T, and myeloperoxidase (MPO) G-463A polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP490846.RAKW0fnF--VY9rWH-674mYCL8A7CsL7AVBJ3eAypkVytw130_provenance.
- NP490846.RAKW0fnF--VY9rWH-674mYCL8A7CsL7AVBJ3eAypkVytw130_assertion evidence source_evidence_literature NP490846.RAKW0fnF--VY9rWH-674mYCL8A7CsL7AVBJ3eAypkVytw130_provenance.
- NP490846.RAKW0fnF--VY9rWH-674mYCL8A7CsL7AVBJ3eAypkVytw130_assertion SIO_000772 20598694 NP490846.RAKW0fnF--VY9rWH-674mYCL8A7CsL7AVBJ3eAypkVytw130_provenance.
- NP490846.RAKW0fnF--VY9rWH-674mYCL8A7CsL7AVBJ3eAypkVytw130_assertion wasDerivedFrom befree-20140225 NP490846.RAKW0fnF--VY9rWH-674mYCL8A7CsL7AVBJ3eAypkVytw130_provenance.
- NP490846.RAKW0fnF--VY9rWH-674mYCL8A7CsL7AVBJ3eAypkVytw130_assertion wasGeneratedBy ECO_0000203 NP490846.RAKW0fnF--VY9rWH-674mYCL8A7CsL7AVBJ3eAypkVytw130_provenance.